Table 5 Final outcome at last follow-up
Therapy | Seizure free till last follow-up | Continued to have seizures | Ave. relapse time | Ave. recovery time ^ | Evolved to Lenox Gestaut variant* |
|---|---|---|---|---|---|
ACTH monotherapy (n = 4) ^^ | 4 | 0 | 2 wks | 2 months | 0 |
Vigabatrin monotherapy (n = 14) ^^ | 14 | 0 | 2 months | 1 month | 0 |
ACTH followed by Vigabatrin (n = 14) | 1 | 13 | 6 months | 3 months | 0 |
Vigabatrin followed by ACTH (n = 24) | 2 | 18 | 2 months | 6 months | 4 |